Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk?

Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk?

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digestive and liver disease 2021-03, Vol.53 (3), p.383-384
Hauptverfasser: Angelico, Francesco, Baratta, Francesco, Pastori, Daniele, Del Ben, Maria
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 384
container_issue 3
container_start_page 383
container_title Digestive and liver disease
container_volume 53
creator Angelico, Francesco
Baratta, Francesco
Pastori, Daniele
Del Ben, Maria
description
doi_str_mv 10.1016/j.dld.2020.12.123
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2480265161</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1590865821000037</els_id><sourcerecordid>2480265161</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-52f81a5c80dc34d1ac48e7bd81a597a474f4a2705f9d1819df83906b531086d3</originalsourceid><addsrcrecordid>eNp9UMtOwzAQtBCI9wdwQT5ySfEjThw4oIq3VMSFu-XaG9UlTYo3KeLvcVTgiLTS7o5mRpoh5IyzCWe8uFxOfOMngon0izRyhxxyXepMqkLspltVLNOF0gfkCHHJmOCFYvvkQMpcS6H0IVlMEQFxBW1Pu5ouYG374Ggd5rHDgDS09GX6MLu7olPawiddN_YL4gj3C6Cwsc2QBF07iiNg8INtqLPRh25j0Q2NjTQGfL85IXu1bRBOf_YxeXu4f7t9ymavj8-301nmpJJ9pkStuVVOM-9k7rl1uYZy7kewKm1e5nVuRclUXXmueeVrLStWzJXkTBdeHpOLre06dh8DYG9WAR00jW2hG9CIXDNRKF7wROVbqktRMUJt1jGsbPwynJmxX7M0qV8z9mu4SCOT5vzHfpivwP8pfgtNhOstAVLGTYBo0AVoHfgQwfXGd-Ef-29Y9YqS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2480265161</pqid></control><display><type>article</type><title>Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk?</title><source>Elsevier ScienceDirect Journals</source><creator>Angelico, Francesco ; Baratta, Francesco ; Pastori, Daniele ; Del Ben, Maria</creator><creatorcontrib>Angelico, Francesco ; Baratta, Francesco ; Pastori, Daniele ; Del Ben, Maria</creatorcontrib><identifier>ISSN: 1590-8658</identifier><identifier>EISSN: 1878-3562</identifier><identifier>DOI: 10.1016/j.dld.2020.12.123</identifier><identifier>PMID: 33483258</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><ispartof>Digestive and liver disease, 2021-03, Vol.53 (3), p.383-384</ispartof><rights>2021 Editrice Gastroenterologica Italiana S.r.l.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-52f81a5c80dc34d1ac48e7bd81a597a474f4a2705f9d1819df83906b531086d3</citedby><cites>FETCH-LOGICAL-c353t-52f81a5c80dc34d1ac48e7bd81a597a474f4a2705f9d1819df83906b531086d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1590865821000037$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33483258$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Angelico, Francesco</creatorcontrib><creatorcontrib>Baratta, Francesco</creatorcontrib><creatorcontrib>Pastori, Daniele</creatorcontrib><creatorcontrib>Del Ben, Maria</creatorcontrib><title>Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk?</title><title>Digestive and liver disease</title><addtitle>Dig Liver Dis</addtitle><issn>1590-8658</issn><issn>1878-3562</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9UMtOwzAQtBCI9wdwQT5ySfEjThw4oIq3VMSFu-XaG9UlTYo3KeLvcVTgiLTS7o5mRpoh5IyzCWe8uFxOfOMngon0izRyhxxyXepMqkLspltVLNOF0gfkCHHJmOCFYvvkQMpcS6H0IVlMEQFxBW1Pu5ouYG374Ggd5rHDgDS09GX6MLu7olPawiddN_YL4gj3C6Cwsc2QBF07iiNg8INtqLPRh25j0Q2NjTQGfL85IXu1bRBOf_YxeXu4f7t9ymavj8-301nmpJJ9pkStuVVOM-9k7rl1uYZy7kewKm1e5nVuRclUXXmueeVrLStWzJXkTBdeHpOLre06dh8DYG9WAR00jW2hG9CIXDNRKF7wROVbqktRMUJt1jGsbPwynJmxX7M0qV8z9mu4SCOT5vzHfpivwP8pfgtNhOstAVLGTYBo0AVoHfgQwfXGd-Ef-29Y9YqS</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Angelico, Francesco</creator><creator>Baratta, Francesco</creator><creator>Pastori, Daniele</creator><creator>Del Ben, Maria</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202103</creationdate><title>Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk?</title><author>Angelico, Francesco ; Baratta, Francesco ; Pastori, Daniele ; Del Ben, Maria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-52f81a5c80dc34d1ac48e7bd81a597a474f4a2705f9d1819df83906b531086d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Angelico, Francesco</creatorcontrib><creatorcontrib>Baratta, Francesco</creatorcontrib><creatorcontrib>Pastori, Daniele</creatorcontrib><creatorcontrib>Del Ben, Maria</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive and liver disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Angelico, Francesco</au><au>Baratta, Francesco</au><au>Pastori, Daniele</au><au>Del Ben, Maria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk?</atitle><jtitle>Digestive and liver disease</jtitle><addtitle>Dig Liver Dis</addtitle><date>2021-03</date><risdate>2021</risdate><volume>53</volume><issue>3</issue><spage>383</spage><epage>384</epage><pages>383-384</pages><issn>1590-8658</issn><eissn>1878-3562</eissn><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33483258</pmid><doi>10.1016/j.dld.2020.12.123</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1590-8658
ispartof Digestive and liver disease, 2021-03, Vol.53 (3), p.383-384
issn 1590-8658
1878-3562
language eng
recordid cdi_proquest_miscellaneous_2480265161
source Elsevier ScienceDirect Journals
title Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T04%3A15%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20hepatic%20fibrosis%20in%20MAFLD:%20A%20new%20player%20in%20the%20evaluation%20of%20residual%20cardiovascular%20risk?&rft.jtitle=Digestive%20and%20liver%20disease&rft.au=Angelico,%20Francesco&rft.date=2021-03&rft.volume=53&rft.issue=3&rft.spage=383&rft.epage=384&rft.pages=383-384&rft.issn=1590-8658&rft.eissn=1878-3562&rft_id=info:doi/10.1016/j.dld.2020.12.123&rft_dat=%3Cproquest_cross%3E2480265161%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2480265161&rft_id=info:pmid/33483258&rft_els_id=S1590865821000037&rfr_iscdi=true